Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:27 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,896,645 7.4% | 75,747 (+4.16%) | View |
| 2023-02-14 4:02 pm Sale | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management L.P. | 556,252 2.2% | -1,304,418 (-70.10%) | View |
| 2023-02-14 09:33 am Purchase | 13G | Krystal Biotech, Inc. KRYS | Avoro Capital Advisors LLC | 1,410,000 5.5% | 1,410,000 (New Position) | View |
| 2023-02-09 11:18 am Purchase | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 2,108,853 8.19% | 130,564 (+6.60%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,698,425 6.6% | 92,929 (+5.79%) | View |
| 2022-02-14 5:07 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,820,898 7.3% | 145,862 (+8.71%) | View |
| 2022-02-14 4:49 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management L.P. | 1,860,670 7.5% | 517,428 (+38.52%) | View |
| 2022-02-09 09:22 am Purchase | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 1,978,289 7.879% | 725,903 (+57.96%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,605,496 6.4% | 198,148 (+14.08%) | View |
| 2021-12-06 5:22 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management L.P. | 1,343,242 5.4% | 1,343,242 (New Position) | View |
| 2021-03-09 4:05 pm Unchanged | 13G | Krystal Biotech, Inc. KRYS | Sun Pharma (Netherlands) B.V. | 914,107 4.1% | 0 (Unchanged) | View |
| 2021-02-16 4:27 pm Sale | 13G | Krystal Biotech, Inc. KRYS | BAKER BROS. ADVISORS LP | 698,874 3.5% | -335,800 (-32.45%) | View |
| 2021-02-16 4:08 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,675,036 8.5% | 584,836 (+53.64%) | View |
| 2021-02-16 12:23 pm Sale | 13G | Krystal Biotech, Inc. KRYS | PRICE T ROWE ASSOCIATES INC | 912 0% | -1,049,673 (-99.91%) | View |
| 2021-02-12 4:55 pm Sale | 13G | Krystal Biotech, Inc. KRYS | ORBIMED ADVISORS LLC | 0 0% | -933,508 (Position Closed) | View |
| 2021-02-08 10:27 am Purchase | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 1,252,386 6.354% | 104,100 (+9.07%) | View |
| 2021-02-04 4:35 pm Unchanged | 13G | Krystal Biotech, Inc. KRYS | Frazier Life Sciences IX L.P. | 895,000 4.5% | 0 (Unchanged) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,407,348 7.1% | 1,407,348 (New Position) | View |
| 2020-02-18 09:15 am Unchanged | 13G | Krystal Biotech, Inc. KRYS | ORBIMED ADVISORS LLC | 933,508 5.39% | 0 (Unchanged) | View |
| 2020-02-14 5:12 pm Purchase | 13G | Krystal Biotech, Inc. KRYS | ORBIMED ADVISORS LLC | 933,508 5.39% | 933,508 (New Position) | View |